AISight Clinical Trials

Deploy AI products and support efficient, remote central pathology reads in clinical trial workflows with the AISight^TM Clinical Trials platform

The AISight¹ Clinical Trials platform is a secure, cloud-based SaaS platform that enables the use of AI-powered algorithms and facilitates digital pathology reads in both prospective and retrospective clinical trials. Supporting eligibility and stratification use cases, response monitoring, quality control, and exploratory analysis, our highly configurable and scalable platform allows for maximum flexibility in leveraging digital pathology in clinical research.

Easy, automated bulk ingestion of whole slide images and metadata on your schedule

Cloud-based, remote access for rapid study startup and result turnaround

Highly configurable and customizable workflows to support even the most complex pathology read strategies

Add-on exploratory features (PathExplore, NASH Explore, IBD Explore)

Providing the highest level of quality and compliance

GCP/GCLP

compliant

21 CFR Part 11

compliant

ISO 27001

certified

Features and Functionality

Quality control analytics supported by dynamic auto-generated data visualizations, including comparison of manual vs. AI scoring concordance with automatically generated kappa values

Easy to use dashboards supporting accession tracking throughout the digital life cycle

Key results at the accession and cumulative levels, segmentable by site or lab and available for direct download through the platform interface

AISight for AP Laboratories

AISight is also available to anatomic pathology labs as a state-of-the-art image management system

Learn More

Contact Us

Connect with our team to learn more about AISight Clinical Trials.

¹AISight is For Research Use Only. Not for use in diagnostic procedures.